Guardant Health Stock Target Price and Analyst Consensus
| GH Stock | USD 49.94 2.29 4.81% |
The current analyst and expert consensus on Guardant Health is Strong Buy with 7 buy recommendations. The current projected Guardant Health target price consensus is 44.10, with 22 analyst opinions. Guardant Health buy-or-sell recommendation module provides average expert sentiment on the projected Guardant Health target price to derive its highest and lowest estimates based on target price estimated volatility of 4.5628. Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Lowest Forecast 40.13 | Highest Forecast 48.95 | Target Price 44.1 |
Guardant |
It's important to approach Guardant Health's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Guardant Health Target Price Consensus
Guardant target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Guardant Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 22 | Strong Buy |
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Guardant Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGuardant Health Target Price Projection
Guardant Health's current and average target prices are 49.94 and 44.10, respectively. The current price of Guardant Health is the price at which Guardant Health is currently trading. On the other hand, Guardant Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Guardant Health Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Guardant Health Target Price
Guardant Health Analyst Ratings
Guardant Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Guardant Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Guardant Health's financials, market performance, and future outlook by experienced professionals. Guardant Health's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Guardant Health price targets
Guardant Health's stock target price is an estimate of its future price, usually made by analysts. Using Guardant Health's target price to determine if it is a suitable investment can be done through the following steps:- Look at Guardant Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Guardant Health's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Guardant Health Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Guardant Health is a key component of Guardant Health valuation and have some predictive power on the future returns of a Guardant Health.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 300 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Driverless Cars Invested few shares | |
 | Banking Invested over 30 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 300 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Manufacturing Invested over 30 shares | |
Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..